The Effect of Antiemetics and Antihistamines on the QTc Interval in Emergent Dialysis Patients With Baseline QTc Prolongation

Scott Burdette, Lynn P. Roppolo, Walter Green, Nashid Shinthia, Peter Ye, Linda S. Hynan

Research output: Contribution to journalArticle

Abstract

Background Unfunded patients with end-stage renal disease (ESRD) who do not have routinely scheduled hemodialysis often receive medications known to prolong the QTc interval for their uremic symptoms even though they may have pre-existing QTc prolongation. Objectives The purpose of this study was to determine the effects of these medications on the QTc interval in these patients. Methods Unfunded patients with ESRD presenting to the emergency department (ED) for emergent hemodialysis (HD) with QTc prolongation on their initial electrocardiogram (ECG) were recruited. Approximately 2 hours after receiving an antihistamine or antiemetic, a second ECG was ordered and the QTc was measured. The patients were followed-up 1 week later. Results Twenty-nine percent (44/152) of the unfunded patients with ESRD presenting for HD at a county hospital had QT prolongation and were included with 107 total ED visits during the 4-week study period. The mean QTc was 483.7 msec on presentation to the ED, and the mean QTc measured 2 hours after receiving an antihistamine or antiemetic was 483.8 msec. None of the patients were admitted for life-threatening dysrhythmias. Thirty-six percent (16/44) of the recruited patients had QTc intervals >500 msec with a combined total of 31 patient visits, of which only 25.8% (8/31) had an increase in the QTc interval after an antihistamine or antiemetic medication was given. None of these patients had adverse outcomes, such a dysrhythmia or death, at 1-week follow-up. Conclusion This study shows that medications known to cause QTc prolongation are safe to use in therapeutic doses in patients with ESRD who have pre-existing QT prolongation. Few patients in this cohort had significantly prolonged QTc intervals at baseline.

Original languageEnglish (US)
Pages (from-to)99-105
Number of pages7
JournalJournal of Emergency Medicine
Volume51
Issue number2
DOIs
StatePublished - Aug 1 2016

Fingerprint

Antiemetics
Histamine Antagonists
Dialysis
Chronic Kidney Failure
Renal Dialysis
Hospital Emergency Service
Electrocardiography
County Hospitals
Therapeutic Uses

Keywords

  • antiemetics
  • antihistamine
  • dialysis
  • ESRD
  • QTc

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

The Effect of Antiemetics and Antihistamines on the QTc Interval in Emergent Dialysis Patients With Baseline QTc Prolongation. / Burdette, Scott; Roppolo, Lynn P.; Green, Walter; Shinthia, Nashid; Ye, Peter; Hynan, Linda S.

In: Journal of Emergency Medicine, Vol. 51, No. 2, 01.08.2016, p. 99-105.

Research output: Contribution to journalArticle

@article{bf361ca55265424a8c65319cbcd7bf78,
title = "The Effect of Antiemetics and Antihistamines on the QTc Interval in Emergent Dialysis Patients With Baseline QTc Prolongation",
abstract = "Background Unfunded patients with end-stage renal disease (ESRD) who do not have routinely scheduled hemodialysis often receive medications known to prolong the QTc interval for their uremic symptoms even though they may have pre-existing QTc prolongation. Objectives The purpose of this study was to determine the effects of these medications on the QTc interval in these patients. Methods Unfunded patients with ESRD presenting to the emergency department (ED) for emergent hemodialysis (HD) with QTc prolongation on their initial electrocardiogram (ECG) were recruited. Approximately 2 hours after receiving an antihistamine or antiemetic, a second ECG was ordered and the QTc was measured. The patients were followed-up 1 week later. Results Twenty-nine percent (44/152) of the unfunded patients with ESRD presenting for HD at a county hospital had QT prolongation and were included with 107 total ED visits during the 4-week study period. The mean QTc was 483.7 msec on presentation to the ED, and the mean QTc measured 2 hours after receiving an antihistamine or antiemetic was 483.8 msec. None of the patients were admitted for life-threatening dysrhythmias. Thirty-six percent (16/44) of the recruited patients had QTc intervals >500 msec with a combined total of 31 patient visits, of which only 25.8{\%} (8/31) had an increase in the QTc interval after an antihistamine or antiemetic medication was given. None of these patients had adverse outcomes, such a dysrhythmia or death, at 1-week follow-up. Conclusion This study shows that medications known to cause QTc prolongation are safe to use in therapeutic doses in patients with ESRD who have pre-existing QT prolongation. Few patients in this cohort had significantly prolonged QTc intervals at baseline.",
keywords = "antiemetics, antihistamine, dialysis, ESRD, QTc",
author = "Scott Burdette and Roppolo, {Lynn P.} and Walter Green and Nashid Shinthia and Peter Ye and Hynan, {Linda S.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.jemermed.2016.04.027",
language = "English (US)",
volume = "51",
pages = "99--105",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - The Effect of Antiemetics and Antihistamines on the QTc Interval in Emergent Dialysis Patients With Baseline QTc Prolongation

AU - Burdette, Scott

AU - Roppolo, Lynn P.

AU - Green, Walter

AU - Shinthia, Nashid

AU - Ye, Peter

AU - Hynan, Linda S.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Background Unfunded patients with end-stage renal disease (ESRD) who do not have routinely scheduled hemodialysis often receive medications known to prolong the QTc interval for their uremic symptoms even though they may have pre-existing QTc prolongation. Objectives The purpose of this study was to determine the effects of these medications on the QTc interval in these patients. Methods Unfunded patients with ESRD presenting to the emergency department (ED) for emergent hemodialysis (HD) with QTc prolongation on their initial electrocardiogram (ECG) were recruited. Approximately 2 hours after receiving an antihistamine or antiemetic, a second ECG was ordered and the QTc was measured. The patients were followed-up 1 week later. Results Twenty-nine percent (44/152) of the unfunded patients with ESRD presenting for HD at a county hospital had QT prolongation and were included with 107 total ED visits during the 4-week study period. The mean QTc was 483.7 msec on presentation to the ED, and the mean QTc measured 2 hours after receiving an antihistamine or antiemetic was 483.8 msec. None of the patients were admitted for life-threatening dysrhythmias. Thirty-six percent (16/44) of the recruited patients had QTc intervals >500 msec with a combined total of 31 patient visits, of which only 25.8% (8/31) had an increase in the QTc interval after an antihistamine or antiemetic medication was given. None of these patients had adverse outcomes, such a dysrhythmia or death, at 1-week follow-up. Conclusion This study shows that medications known to cause QTc prolongation are safe to use in therapeutic doses in patients with ESRD who have pre-existing QT prolongation. Few patients in this cohort had significantly prolonged QTc intervals at baseline.

AB - Background Unfunded patients with end-stage renal disease (ESRD) who do not have routinely scheduled hemodialysis often receive medications known to prolong the QTc interval for their uremic symptoms even though they may have pre-existing QTc prolongation. Objectives The purpose of this study was to determine the effects of these medications on the QTc interval in these patients. Methods Unfunded patients with ESRD presenting to the emergency department (ED) for emergent hemodialysis (HD) with QTc prolongation on their initial electrocardiogram (ECG) were recruited. Approximately 2 hours after receiving an antihistamine or antiemetic, a second ECG was ordered and the QTc was measured. The patients were followed-up 1 week later. Results Twenty-nine percent (44/152) of the unfunded patients with ESRD presenting for HD at a county hospital had QT prolongation and were included with 107 total ED visits during the 4-week study period. The mean QTc was 483.7 msec on presentation to the ED, and the mean QTc measured 2 hours after receiving an antihistamine or antiemetic was 483.8 msec. None of the patients were admitted for life-threatening dysrhythmias. Thirty-six percent (16/44) of the recruited patients had QTc intervals >500 msec with a combined total of 31 patient visits, of which only 25.8% (8/31) had an increase in the QTc interval after an antihistamine or antiemetic medication was given. None of these patients had adverse outcomes, such a dysrhythmia or death, at 1-week follow-up. Conclusion This study shows that medications known to cause QTc prolongation are safe to use in therapeutic doses in patients with ESRD who have pre-existing QT prolongation. Few patients in this cohort had significantly prolonged QTc intervals at baseline.

KW - antiemetics

KW - antihistamine

KW - dialysis

KW - ESRD

KW - QTc

UR - http://www.scopus.com/inward/record.url?scp=84995897749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995897749&partnerID=8YFLogxK

U2 - 10.1016/j.jemermed.2016.04.027

DO - 10.1016/j.jemermed.2016.04.027

M3 - Article

C2 - 27614302

AN - SCOPUS:84995897749

VL - 51

SP - 99

EP - 105

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

SN - 0736-4679

IS - 2

ER -